Background: Kawasaki disease (KD) is an acute systemic vasculitis of small and medium vessels, which occurs primarily in children. Its clinical picture shows as a febrile syndrome combined with vasculitis that can cause coronary artery abnormalities in 25% of untreated patients. The objective of this study was to describe the clinical behavior and to identify risk factors for cardiovascular complications in pediatric patients with KD in the second level hospital in northwestern Mexico. Methods: Under a case series design, we studied pediatric patients with a diagnosis of KD. We measured clinical variables, laboratory values, and the presence of cardiac complications; the probability of risk was determined with an odds ratio (OR) and the association with the Chi-squared test. Results: A total of 12 patients were included in the study, in which the female gender predominated; the mean age of presentation of KD was 2 years. The clinical presentation was complete in 100% of the cases, and patients also presented atypical manifestations; 50% of the patients studied had cardiovascular complications, and the most common was the coronary disease (33%). The variables male gender, age under 2 years, and anemia reported OR of 5.5-10 for suffering cardiovascular complications. Conclusions: Cardiovascular complications of KD are frequent (> 30%). Male gender, age under 2 years, and anemia increase the risk of cardiovascular complications.
Cardiovascular complications of KD are frequent (more than 30%). Male gender, age under 2 years and anemia increase the probability of risk for the presence of cardiovascular complications.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.